Method for processing of fish egg and processed fish egg produced by the method
    1.
    发明授权
    Method for processing of fish egg and processed fish egg produced by the method 失效
    通过该方法生产的鱼蛋和加工鱼蛋的加工方法

    公开(公告)号:US08535742B2

    公开(公告)日:2013-09-17

    申请号:US12527768

    申请日:2008-02-19

    IPC分类号: A23J1/04

    摘要: Provided are a method of processing fish eggs, which can produce fish eggs having a good color tone without using a color-developing agent such as a nitrite or by using a reduced amount of the color-developing agent, and processed fish eggs produced by the method. A lactic acid bacterium, which can improve the color tone of the fish eggs, is added to the fish eggs. The lactic acid bacterium is preferably a lactic acid bacterium belonging to the genus Lactobacillus or Carnobacterium, more preferably Lactobacillus coryniformis K12 (Deposition Number: FERM BP-10945) or Carnobacterium maltaromaticum B64 (Deposition Number: FERM BP-10449).

    摘要翻译: 提供了一种处理鱼卵的方法,其可以生产具有良好色调的鱼卵,而不使用显色剂如亚硝酸盐或通过使用减少量的显色剂,以及加工的鱼蛋 方法。 将可以提高鱼卵色调的乳酸菌添加到鱼卵中。 乳酸菌优选为属于乳杆菌属或Carnobacterium属的乳酸菌,更优选乳酸杆菌K12(保藏号:FERM BP-10945)或麦芽色杆菌B64(保藏号:FERM BP-10449)。

    Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same
    4.
    发明申请
    Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same 有权
    具有抗炎活性的乳杆菌分离物及其用途

    公开(公告)号:US20090274672A1

    公开(公告)日:2009-11-05

    申请号:US12340081

    申请日:2008-12-19

    IPC分类号: A61K35/74 C12N1/20 A23L1/48

    摘要: Disclosed herein are two Lactobacillus isolates having anti-inflammatory activities and beneficial probiotic properties, i.e., Lactobacillus sakei GMNL-76 and Lactobacillus reuteri GMNL-89, which were deposited in the Biosource Collection and Research Center (BCRC) of the Food Industry Research and Development Institute (FIRDI) under accession numbers BCRC 910355 and BCRC 910340 and in the China Center for Type Culture Collection (CCTCC) under accession numbers CCTCC M 207153 and CCTCC M 207154, respectively. The two Lactobacillus isolates and their sub-cultured offspring can be used in the preparation of a variety of food products, and in the manufacture of pharmaceutical compositions for treating and/or alleviating diseases associated with inflammation, such as rheumatoid arthritis.

    摘要翻译: 本文公开了两种具有抗炎活性和有益益生菌特性的分离乳杆菌的乳酸杆菌GMNL-76和赖氨酸乳杆菌GMNL-89,其保藏在食品工业研究与开发的生物源收集和研究中心(BCRC)中 研究所(FIRDI)分别以登记号BCRC 910355和BCRC 910340以及中国类型培养物保藏中心(CCTCC),登录号为CCTCC M 207153和CCTCC M 207154。 两种乳酸杆菌分离物及其亚培养的后代可用于制备各种食品,以及用于制备用于治疗和/或减轻与炎症相关的疾病如类风湿性关节炎的药物组合物。

    Method for Reducing the Content of Pathogenic Organisms Present in Food Materials
    6.
    发明申请
    Method for Reducing the Content of Pathogenic Organisms Present in Food Materials 审中-公开
    减少食品中存在的病原菌的含量的方法

    公开(公告)号:US20080102159A1

    公开(公告)日:2008-05-01

    申请号:US11578331

    申请日:2005-04-15

    IPC分类号: A23B4/12 A23L1/03

    摘要: The present invention relates to a method for reducing the concentration of pathogenic organisms such as Listeria spp. in fermented food products. The method comprises the steps of: (i) providing a food material, (ii) mixing said food material with a starter culture, (iii) mixing the food material with at least one adjunct culture in form of a bacteriocin-producing Pediococcus species, (iv) subjecting the mixture provided in step (iii) to a fermentation process, said fermentation process being conducted at conditions that are sub-optimal for growth of the bacteriocin-producing Pediococcus species in order to provide a limited acidification and allow for a high production of bacteriocin, and obtain a fermented food product. Furthermore, the invention relates to the use of bacteriocin-producing Pediococcus species as an adjunct culture for securing microbial safety of fermented food products.

    摘要翻译: 本发明涉及一种降低致病菌如李斯特氏菌属的浓度的方法。 在发酵食品中。 该方法包括以下步骤:(i)提供食物材料,(ii)将所述食物材料与起始培养物混合,(iii)将所述食物材料与至少一种辅酶培养物以产生细菌素的类球菌属物种形式混合, (iv)将步骤(iii)中提供的混合物进行发酵过程,所述发酵过程在对生产细菌素的类球菌属物种生长是次优的条件下进行,以提供有限的酸化并允许高的 生产细菌素,得到发酵食品。 此外,本发明涉及产生细菌素的类球菌属物种作为辅助培养物以确保发酵食品的微生物安全性的用途。

    Fishes treated with lactic acid bacterium culture medium having antibacterial and antioxidative effects
    7.
    发明申请
    Fishes treated with lactic acid bacterium culture medium having antibacterial and antioxidative effects 审中-公开
    用具有抗菌和抗氧化作用的乳酸菌培养基处理的鱼

    公开(公告)号:US20060204618A1

    公开(公告)日:2006-09-14

    申请号:US10533956

    申请日:2003-11-06

    IPC分类号: A23L1/31

    CPC分类号: A23B4/12 A23B4/22 A23Y2220/77

    摘要: Fish and shellfish meat whose color tone is well preserved, particularly no Listeria contamination and in which discoloration is effectively prevented, and smoked products prepared from such fish and shellfish meat are provided. Fish meat which is no Listeria contamination and in which discoloration is prevented can be obtained by treating the meat with a cultivation medium used for cultivating lactic acid bacteria. Specifically, the meat is immersed preferably in a sterilized or disinfected cultivation medium used for cultivating a lactic acid bacterium having antibacterial and anti-oxidative effects, or two lactic acid bacteria in combination, one having antibacterial effect and the other anti-oxidative effect. Combinational use of Lactobacillus sake D-1001 (FERM P-11708 or IPOD FERM BP-08544) and Lactococcus lactis IFO 12007 is preferred. The fish meat is preferably derived from salmon, trout or cod, and the inventive method is particularly effective for fish meat containing astaxanthin.

    摘要翻译: 提供色泽保持良好的鱼和贝类肉类,特别是没有利斯特氏菌污染,有效防止变色,并且提供从这些鱼和贝类肉制成的熏制产品。 通过用用于培养乳酸菌的培养基处理肉,可以获得不含李斯特菌污染并且防止变色的鱼肉。 具体而言,将肉优选浸渍在用于培养具有抗菌和抗氧化作用的乳酸菌的灭菌或消毒的培养基中,或两种组合的乳酸菌,一种具有抗菌作用和另一种抗氧化作用。 乳酸乳杆菌D-1001(FERM P-11708或IPOD FERM BP-08544)和乳酸乳球菌IFO 12007的组合使用是优选的。 鱼肉优选来自鲑鱼,鳟鱼或鳕鱼,本发明的方法对含有虾青素的鱼肉特别有效。

    Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
    8.
    发明申请
    Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom 有权
    来自唾液乳杆菌的益生菌菌株和由其获得的抗微生物剂

    公开(公告)号:US20040214304A1

    公开(公告)日:2004-10-28

    申请号:US10606114

    申请日:2003-06-26

    IPC分类号: C12N001/20

    摘要: A strain of Lactobacillus salivarius isolated from resected and washed human gastrointestinal tract inhibits a broad range of Gram positive and Gram negative microorganisms and secretes a product having antimicrobial activity into a cell-free supernatant. The activity is produced only by, growing cells and is destroyed by proteinase K and pronase E, the inhibitory properties of the strain and its secretory products being maintained in the presence of physiological concentrations of human bile and human gastric juice. The strain exhibits a broad-spectrum of activity against bacteria including Listeria, Staphylococcus, including methocillin resistant St. aureus (MRSA), and Bacillus, but does not inhibit many closely related lactobacilli. An antirmicrobial agent is obtained from the strain which has bacteriocin-like properties.

    摘要翻译: 从切除和洗涤的人类胃肠道分离的唾液乳杆菌菌株抑制广泛的革兰氏阳性和革兰氏阴性微生物,并将具有抗微生物活性的产物分泌到无细胞上清液中。 该活性仅由生长细胞产生并被蛋白酶K和链霉蛋白酶E破坏,菌株及其分泌产物的抑制性质在生理浓度的人胆汁和人胃液存在下保持。 该菌株对李斯特菌,葡萄球菌(包括耐甲氧西林金黄色葡萄球菌(MRSA))和芽孢杆菌(Bacillus)具有广谱的活性,但不抑制许多密切相关的乳杆菌。 从具有细菌素样性质的菌株获得抗微生物剂。

    Bile acid absorbent/adsorbent
    9.
    发明申请
    Bile acid absorbent/adsorbent 审中-公开
    胆汁酸吸收剂/吸附剂

    公开(公告)号:US20040208859A1

    公开(公告)日:2004-10-21

    申请号:US10485945

    申请日:2004-03-02

    IPC分类号: A61K045/00 A61K031/715

    摘要: The present invention provides a bile acid absorbent/adsorbent comprising as active ingredients a lactic acid bacterium having a property of incorporating bile acids into the cell in the presence of an oligosaccharide and of no releasing them out of the cells, and the oligosaccharide. The lactic acid bacterium includes Lactobacillus salivarius ssp. salicinius strain JCM1044, Bifidobacterium breve strain JCM1192, etc. The oligosaccharide includes raffinose, kestose, nystose, trehalose, etc. The bile acid adsorbent is in a form of oral formulation, or eatables and drinkables, etc. The bile acid absorbent/adsorbent can be utilized as cholesterol lowering agents or colorectal cancer inhibitors.

    摘要翻译: 本发明提供了一种胆汁酸吸收剂/吸附剂,其包含作为活性成分的乳酸菌,其具有在寡糖存在下将胆汁酸并入细胞中,并且不将其从细胞中释放出来的寡糖。 乳酸菌包括唾液乳杆菌(Lactobacillus salivarius) 水杨酸菌株JCM1044,双歧杆菌菌株JCM1192等。寡糖包括棉子糖,海藻糖,蔗糖,海藻糖等。胆汁酸吸附剂是口服制剂或可食用和饮料等的形式。胆汁酸吸收剂/吸附剂 用作胆固醇降低剂或结肠直肠癌抑制剂。

    Lactic acid bacteria-containing probiotics products
    10.
    发明申请
    Lactic acid bacteria-containing probiotics products 有权
    含乳酸菌的益生菌产品

    公开(公告)号:US20030157079A1

    公开(公告)日:2003-08-21

    申请号:US10372323

    申请日:2003-02-25

    IPC分类号: A61K045/00

    摘要: The present invention provides a probiotics product comprising, as an effective component, lactic acid bacteria belonging to Lactobacillus salivarius possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids, a composition for preventing and/or treating digestive tract's diseases comprising the probiotics product as an effective component and a novel Lactobacillus salivarius strain possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids. The lactic acid bacteria and the probiotics product and the composition for preventing and/or treating digestive tract's diseases, which contain the lactic acid bacteria as an effective component, according to the present invention can sufficiently show their probiotics functions without being easily discharged from the digestive tract and urinogenital organs.

    摘要翻译: 本发明提供一种益生菌产品,其包含属于对粘膜具有高粘附性,高增殖能力和高耐酸性的唾液乳杆菌的乳酸菌作为有效成分,用于预防和/或治疗消化道疾病的组合物 包括作为有效成分的益生菌产品和对粘膜具有高粘附性,高增殖能力和高耐酸性的新型唾液乳杆菌菌株。 根据本发明的含有乳酸菌作为有效成分的乳酸菌和益生菌产品以及用于预防和/或治疗消化道疾病的组合物可充分显示其益生菌功能,而不易从消化道排出 管道和尿生殖器官。